FACTORS ASSOCIATED WITH MORTALITY IN PATIENTS WITH GASTRIC CANCER AT A REFERENCE HOSPITAL

Francisca Bruna Arruda Aragão, Gerusinete Rodrigues Bastos dos Santos, Gabrielle Vieira da Silva Brasil, Bruno Carvalho Campelo, Ana Patrícia Fonseca Coelho Galvão, Joelmara Furtados dos Santos Pereira, Rodrigo Rodrigues Vasques, Fábio Vidal de Figueiredo, Ana Mônica Abreu dos Santos de Oliveira, Jaqueline Diniz Pinho, Rodrigo Lopes da Silva

Abstract


Background: Gastric cancer (GC) is the second cause of death by tumor in the world. In Brazil, the survival rate of patients with GC is only five years, due to the low rates of early diagnosis, with about 10 to 15% of the cases. Thus, this study aims to evaluate the factors associated with mortality in CG patients treated at a reference hospital. Method: The study was carried out based on the survey of 96 medical records of patients diagnosed with GC, whose analyzed data were: sex, age, educational level, occupation (socioeconomic level), and risk factors, such as smoking, alcohol consumption, family history of cancer, staging and type of treatment adopted, among other variables. Statistical analysis was performed using the Statistical Package for the Social Sciences (SPSS-PC) and Kaplan-Meier for survival analysis. Absolute and relative frequencies were calculated for all variables. Results: The sample consisted mainly of male patients with stable union, brown-colored, who lived in the metropolitan region and presented low schooling. In addition, risk factors such as smoking and alcoholism presented a high prevalence in the sample. Regarding mortality, factors such as arterial hypertension (p = 0.1581), diabetes (p = 0.3212), and alcohol consumption (p = 0.6704) were not associated with increased mortality in this study. Conclusion: The clinical and epidemiological profile of patients with GC presented a low degree of tumor differentiation, with predominance of the mixed or unclassifiable subtype. In addition, the majority of the sample was composed of patients living in the metropolitan region and the main form of treatment adopted was surgical intervention in combination with chemotherapy.


Full Text:

PDF (FULL TEXT)

References


Aguiar Jr P, Stocka G, Barão K, Forones N. Chemotherapy for elderly patients with gastric cancer: experience of a Brazilian center. Geriatr Gerontol Aging. 2016; 10:71-9.

Ajani J, Barthel J, Bekaii-Saab T. NCCN Clinical practice guidelines in oncology. Gastric Cancer. 2010; 2.

Araújo Júnior ON, Alexandre ATV, Barboza DRMM, Meireles MS, Pinheiro MV, Pinheiro ATM. Perfil epidemiológico e histopatológico do câncer gástrico. Cadernos ESP. 2013;5: 26-33.

Andreollo NA, Lopes LR, Neto C, de Souza J. Complicações pós-operatórias após gastrectomia total no câncer gástrico: análise de 300 doentes. ABCD Arq Bras Cir Dig. 2011;24:126-30.

Brasil. Saúde BMd. Conselho Nacional de Saúde. Resolução nº. 196 de 10 de outubro de 1996. Diretrizes e Normas Regulamentadoras de Pesquisas Envolvendo Seres Humanos: Diário Oficial da União; 1996.

Cabral PG, Moura KM, Teixeira MCA, dos Santos Fernandes G. Resposta completa e duradoura em câncer gástrico metastático HER2-positivo. Rev Sau Faciplac. 2016;3:28-32.

Carcas LP. Gastric cancer review. Journal of Carc. 2014; 13:1-14.

Chen S, Rao H, Liu J, et al. Lymph nodes ratio based nomogram predicts survival of resectable gastric cancer regardless of the number of examined lymph nodes. Oncotar. 2017; 8:455-85.

Colombi S, Baia RdSM. Sistematização da assistência de enfermagem a um paciente de gastrectomia total: relato de experiência. Nursin. 2015;18: 986-90.

Cóvos FHG, Ferreira FMF, Navarro PF, Magalhães P, David WRdFJ, Malheiros CA. Câncer gástrico avançado: complicação pós operatória–discussão de caso. Arq Med Hosp Fac Cienc Med Santa Casa São Paulo. 2011;56:145-9.

Dalla Valle T, Turrini RNT, de Brito Poveda V. Fatores intervenientes para o início do tratamento de pacientes com câncer de estômago e colorretal. Rev Latino-Am Enfermagem. 2017;25:1-9.

Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Inter of Gastro Oncology. 2015;136(5).

Hur H, Paik MJ, Xuan Y, et al. Quantitative measurement of organic acids in tissues from gastric cancer patients indicates increased glucose metabolism in gastric cancer. PLoS One. 2014;9:e98581.

Hu B, El Hajj N, Sittler S, Lammert N, Barnes R, Meloni-Ehrig A. Gastric cancer: Classification, histology and application of molecular pathology. Journ of Gastro Oncology. 2012;3(3):251.

Inca I. Estimativa de cancer no Brasil 2014, p. 2016.

Inca I. Estimativa de cancer no Brasil 2016, p. 2016.

Khedmat H, Panahian M, Mashahdian M, Rajabpour MV, Zendehdel K. Prognostic Factors and Survival in Stomach Cancer–Analysis of 15 Years of Data from a Referral Hospital in Iran and Evaluation of International Variation. Onc Researh and Treat. 2011;34(4):178-182.

Mutiladoras C. Estratégias de enfrentamento utilizadas pelos pacientes oncológicos submetidos a cirurgias mutiladoras. Rev Bras Cancerol. 2009;55:355-64.

Network. NCC Clinical Practice Guidelines in Oncology: Gastric Cancer Version 3. 2015.

Park DJ, Thomas NJ, Yoon C, Yoon SS. Vascular endothelial growth factor a inhibition in gastric cancer. Gastric Canc. 2015;18:33-42.

Pereira APdS, Cesarino CB, Martins MRI, Pinto MH, Netinho JG. Associations among socio-demographic and clinical factors and the quality of life of ostomized patients. Rev Latino-Am Enfermagem. 2012;20:93-100.

Pirini F, Noazin S, Jahuira-Arias MH, et al. Early detection of gastric cancer using global, genome-wide and IRF4, ELMO1, CLIP4 and MSC DNA methylation in endoscopic biopsies. Oncotar. 2017;8:38501-16.

Sales ML, Guimarães AVS. Fatores de risco no desenvolvimento de câncer gástrico. Rev Bras Ciênc Vida. 2017;5:1-24.

Seabra AD, Araújo TMT, Mello FAR, et al. High-density array comparative genomic hybridization detects novel copy number alterations in gastric adenocarcinoma. Antican resear. 2014;34:6405-15.

Sekiguchi M, Oda I, Suzuki H, et al. Clinical outcomes and prognostic factors in gastric cancer patients aged≥ 85 years undergoing endoscopic submucosal dissection. Gastro endosco. 2017;85:963-72.

Sena PP. Instituto Nacional de Câncer. 2015.

Silva JC, Rulim MAB, Moreira AC, et al. Perfil dos pacientes submetidos à gastrectomia por câncer gástrico em um hospital terciário da região do cariri. Biomed & Health Scien. 2017;1:4-12.

Silva RD, Dias MAI. Incidência do carcinoma basocelular e espinocelular em usuários atendidos em um hospital de câncer. REFACS. 2017;5:228-34.

Smyth E, Verheij M, Allum W, Cunningham D, Cervantes A, Arnold D. Gastric cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Onco. 2016;27(suppl_5):v38-v49.

Sousa MTDd, Savassi-Rocha PR, Cabral MMDÁ. Impact of using a lymph node revealing solution in surgical specimens for pathological staging of gastric cancer. Jornal Bras Pat Med Labor. 2014;50:445-51.

Subirat Esquivel L, Guillén Isern D. Algunas consideraciones actuales sobre el Cáncer Gástrico. Rev Arch Med Camagüey. 2011;15:400-11.

Valle TD, Turrini RNT, Poveda VdB. Intervening factors for the initiation of treatment of patients with stomach and colorectal cancer. Rev Latino-Am Enfermagem. 2017;25:1-9.

Wachtel MS, Zhang Y, Chiriva-Internati M, Frezza EE. Different regression equations relate age to the incidence of Lauren types 1 and 2 stomach cancer in the SEER database: these equations are unaffected by sex or race. BMC cancer. 2006;6:1-11

White MC, Holman DM, Boehm JE, Peipins LA et al. Age and cancer risck: a potentially modifiable relastionship. Am J Prev Med. 2015; 46:1-16.

World Health Organization. Globocan 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. IARC Cancer Bases. 2012:1:1-6.

Zhou F, Shi J, Fang C, Zou X, Huang Q. Gastric carcinomas in young (younger than 40 years) chinese patients: clinicopathology, family history, and postresection survival. Medic. 2016;95:1-11.

Zilberstein B, Mucerino DR, Yagi OK, et al. Results of D2 gastrectomy for gastric cancer: lymph node chain dissection or multiple node resection? ABCD Arq Bras Cir Dig. 2012;25:161-4.




DOI (PDF (FULL TEXT)): http://dx.doi.org/10.31557/APJCC.2019.4.3.65

Refbacks

  • There are currently no refbacks.


Copyright (c) 2019 Asia Pacific Journal of Cancer Care


 

  

PORTICO

 

Asia Pacific Organization for Cancer Prevention 

West Asia Organization for Cancer Prevention